Kestra Medical Technologies, Ltd. Common Stock (KMTS) - Total Assets
Based on the latest financial reports, Kestra Medical Technologies, Ltd. Common Stock (KMTS) holds total assets worth $246.70 Million USD as of October 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See KMTS net assets for net asset value and shareholders' equity analysis.
Kestra Medical Technologies, Ltd. Common Stock - Total Assets Trend (2020–2025)
This chart illustrates how Kestra Medical Technologies, Ltd. Common Stock's total assets have evolved over time, based on quarterly financial data.
Kestra Medical Technologies, Ltd. Common Stock - Asset Composition Analysis
Current Asset Composition (April 2025)
Kestra Medical Technologies, Ltd. Common Stock's total assets of $246.70 Million consist of 86.3% current assets and 13.7% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 80.3% |
| Accounts Receivable | $8.08 Million | 2.7% |
| Inventory | $6.57 Million | 2.2% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2020–2025)
This chart illustrates how Kestra Medical Technologies, Ltd. Common Stock's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see how much is Kestra Medical Technologies, Ltd. Common worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Kestra Medical Technologies, Ltd. Common Stock's current assets represent 86.3% of total assets in 2025, an increase from 78.3% in 2020.
- Cash Position: Cash and equivalents constituted 80.3% of total assets in 2025, up from 73.1% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2020.
- Asset Diversification: The largest asset category is accounts receivable at 2.7% of total assets.
Kestra Medical Technologies, Ltd. Common Stock Competitors by Total Assets
Key competitors of Kestra Medical Technologies, Ltd. Common Stock based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087
|
China | CN¥12.14 Billion |
|
Vizionfocus Inc.
TW:4771
|
Taiwan | NT$6.53 Billion |
|
MEDIMI AB AK
F:79T
|
Germany | €1.70 Million |
|
Ansell Ltd
AU:ANN
|
Australia | AU$3.32 Billion |
|
Nanosonics Ltd
AU:NAN
|
Australia | AU$272.48 Million |
|
SDI Ltd
AU:SDI
|
Australia | AU$141.20 Million |
|
Austco Healthcare Ltd
AU:AHC
|
Australia | AU$91.07 Million |
|
Trajan Group Holdings Ltd
AU:TRJ
|
Australia | AU$192.32 Million |
Kestra Medical Technologies, Ltd. Common Stock - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 5.47 | 2.81 | 2.00 |
| Quick Ratio | 5.27 | 2.67 | 2.00 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $159.66 Million | $56.62 Million | $6.79 Million |
Kestra Medical Technologies, Ltd. Common Stock - Advanced Valuation Insights
This section examines the relationship between Kestra Medical Technologies, Ltd. Common Stock's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 8.33 |
| Latest Market Cap to Assets Ratio | 4.30 |
| Asset Growth Rate (YoY) | 543.6% |
| Total Assets | $295.74 Million |
| Market Capitalization | $1.27 Billion USD |
Valuation Analysis
Premium Asset Valuation: The market values Kestra Medical Technologies, Ltd. Common Stock's assets at a significant premium (4.30x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: Kestra Medical Technologies, Ltd. Common Stock's assets grew by 543.6% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Kestra Medical Technologies, Ltd. Common Stock (2020–2025)
The table below shows the annual total assets of Kestra Medical Technologies, Ltd. Common Stock from 2020 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-04-30 | $295.74 Million | +543.64% |
| 2024-04-30 | $45.95 Million | +18.87% |
| 2023-04-30 | $38.66 Million | +26.65% |
| 2021-04-30 | $30.52 Million | +287.68% |
| 2020-04-30 | $7.87 Million | -- |
About Kestra Medical Technologies, Ltd. Common Stock
Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company's develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, thera… Read more